The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Analysis of plasma KIM-1 as a biomarker for recurrence risk after resection for localized renal cell carcinoma.
 
Wenxin Xu
No Relationships to Disclose
 
Maneka Puligandla
No Relationships to Disclose
 
Brian Halbert
No Relationships to Disclose
 
Naomi B. Haas
Consulting or Advisory Role - Calithera Biosciences; Eisai; Exelixis; Merck Sharp & Dohme; Pfizer
Expert Testimony - Lilly (I)
 
Keith Flaherty
Stock and Other Ownership Interests - Apricity Health; Checkmate Pharmaceuticals; Clovis Oncology; FOGPharma; Fount Therapeutics; Kinnate Biopharma; Loxo; Oncoceutics; PIC Therapeutics; Shattuck Labs; Strata Oncology; Tvardi Therapeutics; X4 Pharma
Consulting or Advisory Role - Adaptimmune; Aeglea Biotherapeutics; Amgen; Array BioPharma; Asana Biosciences; Boston Biomedical; Bristol-Myers Squibb; Cell Medica; Debiopharm Group; FOGPharma; Genentech; Incyte; Lilly; Loxo; Merck; Neon Therapeutics; Novartis; Oncoceutics; Pierre Fabre; Roche; Sanofi; Shattuck Labs; Takeda; Tolero Pharmaceuticals; Tvardi Therapeutics; Verastem
Research Funding - Novartis; Sanofi
Travel, Accommodations, Expenses - Debiopharm Group; Pierre Fabre
 
Robert Guy Uzzo
Consulting or Advisory Role - Amgen; Genentech/Roche; Pfizer; Urogen pharma
Speakers' Bureau - Janssen Oncology
Research Funding - Novartis
 
Janice P. Dutcher
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb/Medarex; Clinigen Group; Eisai; Iovance Biotherapeutics; Merck; Nektar; Nektar; Prometheus; TRACON Pharma
 
Robert S. DiPaola
No Relationships to Disclose
 
Venkata Sabbisetti
Patents, Royalties, Other Intellectual Property - Circulating KIM-1 for detection of kidney cancer
 
Rupal Satish Bhatt
Patents, Royalties, Other Intellectual Property - Ang 1-7 as a therapeutic for RCC